[1] 王亦君,冯舒涵,程锦堂,等.大黄蒽醌类化学成分和药理作用研究进展[J].中国实验方剂学杂志,2018,24(13):227
WANG YJ, FENG SH, CHENG JT, et al. Research progress on chemical constituents and pharmacological action of Anthraquinone in Rhei Radix et Rhizoma[J].Chin J Exp Tradit Med Form, 2018, 24(13):227
[2] 王玉,杨雪,夏鹏飞,等.大黄化学成分、药理作用研究进展及质量标志物的预测分析[J].中草药,2019, 50(19):4821
WANG Y, YANG X, XIA PF, et al. Research progress on chemical composition and pharmacological effects of Rhei Radix et Rhizoma and predictive analysis on quality markers[J].Chin Tradit Herb Drugs, 2019, 50(19):4821
[3] 王志旺,郭玫,马丹,等.不同产地大黄对高脂血症大鼠血脂及抗氧化作用的影响[J].中国应用生理学杂志,2015,31(3):278
WANG ZW, GUO M, MA D, et al. Effects of Rhubarbs from different regions on blood lipid and antioxidation of hyperlipidemia rats[J].Chin J Appl Physiol, 2015, 31(3):278
[4] 王成,代旭阳,龚莉虹,等.大黄素对高脂血症斑马鱼脂质代谢的作用研究[J].天然产物研究与开发,2019,31(11):1873
WANG C, DAI XY, GONG LH, et al. Effects of emodin on lipid metabolism in zebrafish with hyperlipidemia[J].Nat Prod Res Dev, 2019, 31(11):1873
[5] 朱慧,刘晓,祝婷婷,等.熟大黄水煎液中化学成分含量测定及其药效学研究[J].南京中医药大学学报,2017,33(05):470
ZHU H, LIU X, ZHU TT, et al. Determination of the related components in perpared Rhubarb Decoction and its pharmacodynamics study[J].J Nanjing Univ Tradit Chin Med, 2017, 33(5):470
[6] 顾家珲.大黄治疗便秘、降血脂的有效物质研究[D]. 兰州:甘肃中医学院, 2013
GU JH. Study on Effective Substances of Rhubarb in Treating Constipation and Lowering Blood Lipid[D].Lanzhou: Gansu College of Traditional Chinese Medicine, 2013
[7] 杨蕊菁,顾家珲,朱顺娟,等.基于变异系数权重的模糊物元模型评价大黄不同提取部位降血脂的效果[J].中国临床药理学杂志,2018,34(2):169
YANG RJ, GU JH, ZHU SJ, et al. Evaluating the effect of reducing blood lipid in different parts of Rheum palmatum L. with Fuzzy matter-element model based on variation coefficient weight[J].Chin J Clin Pharmacol, 2018, 34(2):169
[8] 贺浪冲,耿信笃.细胞膜受体色谱法-研究药物与受体作用的新方法[J].生物医药色谱新进展,1996,3:8
HE LC, GENG XD. Cell membrane receptor chromatography-A new approach to the study of drugs and receptors [J].New Dev Biomed Chromatogr, 1996, 3:8
[9] 方艺霖,张艺,肖小河,等.细胞膜色谱技术用于中药活性成分筛选的研究进展[J].中草药,2008,39(11):3
FANG YL, ZHANG Y, XIAO XH, et al. Advances in studies on application of cell membrane chromatography in screening bioactive components of Chinese materia medica[J].Chin Tradit Herb Drugs, 2008, 39(11): 3
[10] 王晓宇,陈啸飞,顾妍秋,等.细胞膜色谱研究进展及其在中药活性成分筛选中的应用[J].分析化学,2018,46(11):1695
WANG XY, CHEN XF, GU YQ, et al. Progress of cell membrane chromatography and its application in screening active ingredients of Traditional Chinese Medicine[J].Chin J Anal Chem, 2018, 46(11):1695
[11] 贺浪冲,杨广德,耿信笃.固定在硅胶表面细胞膜的酶活性及其色谱特性[J].科学通报,1999,44(6):632
HE LCH, YANG GD, GEN XD. Enzyme activity and chromatographic properties of cell membrane immobilized on silica surface[J].Chin Sci Bull, 1999, 44(6): 632
[12] 王成,胡乃华,余琳媛,等.降脂模型研究进展[J].中国比较医学杂志, 2020,30(4):121
WANG C, HU NH, YU LY, et al. Progress in lipid-lowering model research[J].Chin J Comp Med, 2020, 30(4):121
[13] 罗燕,和兴萍,李雪,等.几种细胞脂肪变性模型的建立与比较分析[J].中华中医药学刊, 2017, 35(8):2074
LUO Y, HE XP, LI X, et al. Establishment and comparative analysis of several kinds of cell fatty degeneration model[J].Chin Arch Trad Chin Med, 2017, 35(8):2074
[14] 殷锦锦,唐外姣,曾璐,等.人肝细胞系L-02细胞单纯肝脂肪变性细胞模型的建立与应用[J].南方医科大学学报,2014,34(6) :837
YING JJ, TANG WJ, ZENG L, et al. Establishment of a L-02 cell model of hepatic steatosis[J].J South Med Univ, 2014, 34(6): 837
[15] 刘楠楠,李虎,彭宗根.肝脂肪变性细胞实验模型与机制研究进展[J].国际药学研究杂志,2019,46(3):171
LIU NN, LI H, PENG ZG. Cellular models and pathogenesis of hepatic steatosis in vitro:research advances[J].J Int Pharm Res, 2019, 46(3):171
[16] 胡启蒙,陈朝银,庄馨英,等. 建立L-02肝细胞脂肪变模型方法比较及脂肪乳诱导脂变条件的优化[J].中国医学物理学杂志,2015,32(4) :469
HU QM,CHEN CY,ZHU XY, et al. Assessment on different methods for establishing hepatocyte L-02 steatosis models and optimization of the steatosis induced by medical fat emulsion[J].Chin J Med Phys, 2015, 32(4) :469
[17] 王炳芳,朱韶杰,田培营.脂肪肝细胞模型的建立及其生物学特征[J].世界华人消化杂志,2007,15(35):3674
WANG BF, ZHU SJ, TIAN PY. Establishment of a cellular model of non-alcoholic fatty liver and its biological characteristics[J].World Chin J Dige, 2007, 15(35):3674
[18] 丁璇. 经APTES共价修饰后的细胞膜色谱新技术的研发及应用[D].上海:第二军医大学,2017
DING X. Development and Applications of New Cell Membrane Chromatography Covalently Decorated by APTES[D].Shanghai:Second Military Medical University, 2017
[19] HAN SHL, LV YN, WEI F, et al. Screening of bioactive components from traditional Chinese medicines using cell membrane chromatography coupled with mass spectrometry[J].Phytochem Anal, 2018, 29(4): 1
[20] 吕艳妮,付佳,孔利云,等.细胞膜色谱在线HPLC-IT-TOF MS联用系统筛选分析射干中次野鸢尾黄素的抗EGFR活性作用[J].质谱学报,2017,38(4):425
LÜ YN, FU J, KONG LY, et al. EGFR antagonism of the irisflorentin from Rhizoma Belamcandae using CMC-Online-HPLC-IT-TOF MS system[J].J Chin Mass Spect Soci, 2017, 38(4):425
[21] 杨广德,贺浪冲,边晓丽,等. 胰岛β-细胞膜色谱模型建立及其生物亲合特性[J].科学通报,2005,50(16):1709
YANG GD, HE LC, BIAN XL, et al. Establishment of β-cell membrane chromatographic model and its biological affinity[J].Chin Sci Bull, 2005, 50(16): 1709
[22] 冯素香,王哲,郝蕊,等. HPLC法同时测定不同产地掌叶大黄中10个蒽醌类化合物[J].药物分析杂志,2017,37(5):783
FENG SX, WANG ZH, HAO R, et al. Simultaneous determination of ten anthraquinones in Rheum palmatum L.from different habitants by HPLC[J].Chin J Pharm Anal, 2017, 37(5):783
[23] 王韵,赵亮,柴逸峰,等.RP-HPLC法同时测定茵陈蒿汤中14个成分[J].药物分析杂志,2017,37(3):393
WANG Y, ZHAO L, CHAI YF, et al. Simultaneous determination of fourteen constituents in Yin-Chen-Hao-Tang by RP-HPLC[J].Chin J Pharm Anal, 2017, 37(3):393
[24] 谭鹏,张海珠,张青,等.UPLC法同时测定大黄中10个蒽醌衍生物的含量[J].中草药, 2018,49(4):928
TAN P, ZHANG HZ, ZHANG Q, et al. Simultaneous determination of 10 anthraquinone derivatives in Rhei Radix et Rhizoma based on UPLC[J].Chin Tradit Herb Drugs, 2018, 49(4):928
[25] YE FY, YANG RJ, HUA X, et al. Adsorption characteristics of rebaudioside A and stevioside on cross-linked poly(styrene-co-divinylbenzene) macroporous resins functionalized with chloromethyl, amino and phenylboronic acid groups[J].Food Chem, 2014, 159 (15):38
[26] 马文苑,谢媛媛,王义明,等.细胞膜色谱技术在中药质量评价中的应用与思考[J].药学学报,2017,52(12):1827
MA WY, XIE YY, WANG YM, et al. Emerging application and reflections of cell membrane chromatography in the quality evaluation of traditional Chinese medicine[J].Acta Pharm Sin, 2017,52(12):1827
